Differential effects of insulin sensitivity on androgens in obese women with polycystic ovary syndrome or normal ovulation

Metabolism: Clinical and Experimental

Volumn 57, Issue 10, 2008, Pages 1355-1360

  Asagami, Tomoko ^a   Holmes, Tyson H ^b   Reaven, Gerald ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; GLUCOSE; TESTOSTERONE;

ADULT; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); DISEASE CLASSIFICATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; OBESITY; OVARY POLYCYSTIC DISEASE; OVULATION; PRIORITY JOURNAL; STEADY STATE; TESTOSTERONE BLOOD LEVEL;

ADULT; ANDROSTENEDIONE; BLOOD GLUCOSE; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; OBESITY; POLYCYSTIC OVARY SYNDROME; TESTOSTERONE;

EID: 51649119826     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2008.05.002     Document Type: Article

References (32)

1. Dunaif A., Segal K.R., Futterweit W., and Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38 (1989) 1165-1174
2. Holte J. Disturbances in insulin secretion and sensitivity in women with the polycystic ovary syndrome. Bailliere's Clin Endocrinol Metab 10 (1996) 221-247
3. Dunaif A. Insulin resistance and the polycystic ovary syndrome; mechanism and implications for pathogenesis. Endocr Rev 18 (1997) 774-800
4. Legro R.S., Finegood D., and Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 83 (1998) 2694-2698
5. Godarzi M.O., and Korenman S.G. The importance of insulin resistance in polycystic ovary syndrome. Fertil Steril 80 (2003) 255-258
6. Salehi M., Bravo-Vera R., Sheikh A., Gouller A., and Poretsky L. Pathogenesis of polycystic ovary syndrome: what is the role of obesity?. Metabolism 53 (2004) 358-376
7. Olefsky J., Reaven G.M., and Farquhar J.W. Effects of weight reduction on obesity studies of lipid and carbohydrate metabolism in normal and hyperlipoproteinemic subjects. J Clin Invest 53 (1974) 64-76
8. Reaven G.M. Obesity, insulin resistance, and cardiovascular disease. Recent Progress. Horm Res 59 (2004) 207-223
9. McLaughlin T., Abbasi F., Cheal K., Chu J., Lamendola C., and Reaven G. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med 139 (2003) 802-809
10. McLaughlin T., Allison G., Abbasi F., Lamendola C., and Reaven G. Prevalence of insulin resistance and associated cardiovascular disease risk factors among normal weight, overweight, and obese individuals. Metabolism 53 (2004) 495-499
11. Acien P., Quereda F., Matallin P., Villarroya E., Lopez-Fernandez J.A., Acien M., et al. Insulin, androgens, and obesity in women with and without polycystic ovary syndrome: a heterogeneous group of disorders. Fertil Steril 72 (1999) 32-40
12. Burghen G.A., Givens J.R., and Kitabchi A.E. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab 50 (1980) 113-116
13. Gambineri A., Pelusi C., Vicennati V., Pagotto U., and Pasquali R. Obesity and the polycystic ovary syndrome. Int J Obes Relat Metab Disord 26 (2002) 883-896
14. National Institutes of Health clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report (1998), National Institutes of Health, United States Department of Health and Human Services, Bethesda, MD
15. Pei D., Jones C.N., Bhargava R., Chen Y.D., and Reaven G.M. Evaluation of octreotide to assess insulin-mediated glucose disposal by the insulin suppression test. Diabetologia 37 (1994) 843-845
16. Shen S.W., Reaven G.M., and Farquhar J.W. Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes. J Clin Invest 49 (1970) 2151-2160
17. Greenfield M.S., Doberne L., Kraemer F., Tobey T.A., and Reaven G.M. Assessment of insulin resistance with the insulin suppression test and the euglycemic clamp. Diabetes 30 (1981) 387-392
18. Yeni-Komshian H., Carantoni M., Abbasi F., and Reaven G.M. Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers. Diabetes Care 23 (2000) 171-175
19. Yip J., Facchini F.S., and Reaven G.M. Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease. J Clin Endocrinol Metab 83 (1998) 2773-2776
20. Facchini F.S., Hua N., Abbasi F., and Reaven G.M. Insulin resistance as a predictor of age-related diseases. J Clin Endocrinol Metab 86 (2001) 3574-3578
21. Cochran W.G., and Cox G.M. Experimental designs (1950), John Wiley & Sons, Inc., New York, NY
22. Rice W.R. Analyzing tables of statistical tests. Evolution 43 (1989) 223-225
23. Baillargeon J.P., and Nestler J.E. Polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin. J Clin Endocrinol Metab 91 (2005) 22-24
24. Baillargeon J.P., and Carpentier A. Role of insulin in the hyperandrogenemia of lean women with polycystic ovary syndrome and normal insulin sensitivity. Fertil Steril 88 (2007) 886-893
25. Gilling-Smith C., Willis D.S., Beard R.W., and Frank S. Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries. J Clin Endocrinol Metab 79 (1994) 1158-1165
26. Willis D., Mason H., Gilling-Smith C., and Frank S. Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries. J Clin Endocrinol Metab 81 (1996) 302-309
27. Franks S., Gharani N., and Gilling-Smith C. Polycystic ovary syndrome: evidence for a primary disorder of ovarian steroidogenesis. J Steroid Biochem Mol Biol 69 (1999) 269-272
28. Franks S., Gilling-Smith C., Watson H., and Willis D. Insulin action in the normal and polycystic ovary. Endocrinol Metab Clin North Am 28 (1999) 361-378
29. Miller K.K., Rosner W., Lee H., et al. Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods. J Clin Endocrinol Metab 89 (2004) 525-533
30. Nestler J.E., Jakubowicz D.J., de Vargas A.F., et al. Insulin stimulates testosterone biosynthesis by human theca cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J Clin Endocrinol Metab 83 (1998) 2001-2205
31. Abbasi F., and Reaven G.M. Evaluation of the quantitative insulin sensitivity check index as an estimate of insulin sensitivity in humans. Metabolism 51 (2002) 235-237
32. Kim S.H., Abbasi F., and Reaven G.M. Impact of degree of obesity on surrogate estimates of insulin resistance. Diabetes Care 27 (2004) 1998-2002